期刊文献+

原发中枢神经系统淋巴瘤

Primary Central Nervous System Lymphoma
下载PDF
导出
摘要 目的:分析11例中枢淋巴瘤的临床特点及预后。方法:收集我院2007年至2013年11例原发性中枢神经系统淋巴瘤患者的临床资料进行回顾性分析,并参考近年来国内外文献,对原发中枢神经系统淋巴瘤的临床特征及其疗效预后进行探讨。结果:11例患者经放化疗结合治疗后并随访暂无复发,3例患者术后放化疗治疗后复发在化疗并随访中,患者恢复良好。11例患者5年总生存率“OS”为50%。结论:原发中枢神经系统淋巴瘤早期临床诊断困难,明确病理类型后,大剂量甲氨蝶呤化疗是其主要治疗方法,并同步放化疗的综合治疗措施,能提高患者生存质量,延长生存期。 Purpose: Study of clinical features and prognosis of 11 CNS (central nervous system) lymphoma cases. Methods: Discuss on the clinical features and prognosis of the CNS lymphoma by analyzing clinical files of the primary CNS lymphoma patients in our hospital from 2007 to 2013 with recent domestic and international studies for reference. Results: 11 patients temporarily show no relapse of CNS lymphoma after radiotherapies, chemotherapies and follow-up clinic visits. 3 patients relapse after radical and chemical therapies but recover well after follow-up visits in hospital. The general OS survival rate of the 11 cases is 50%. Conclusion: It is difficult to diagnose clinically of the primary CNS lymphoma at its early stage. Large dose of using methotrexate is the main treating method after diagnosis of its pathological mechanism. With synchronous radiotherapy and chemotherapy, the living quality and life span of patients would be enhanced accordingly.
机构地区 贵州省肿瘤医院
出处 《临床医学进展》 2015年第3期131-135,共5页 Advances in Clinical Medicine
  • 相关文献

参考文献3

二级参考文献29

  • 1胡毅,冯奉仪,石远凯,周立强,顾大中,王奇璐.原发性中枢神经系统淋巴瘤28例临床分析[J].中华肿瘤杂志,2004,26(6):375-378. 被引量:22
  • 2徐兵河 顾大中.中枢神经系统恶性淋巴瘤[A].王奇璐主编.恶性淋巴瘤的诊断与治疗[C].北京:北京医科大学中国协和医科大学联合出版社,1997.346.
  • 3Poortmans P M,Kluin-Nelemans H C,Haaxma-Reiche H,et al.High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma:European Organization for Research and Treatment of Cancer Lymphoma Group Phase Ⅱ Trial20962[J].J Clin Oncol,2003,21(24):4483-4488.
  • 4Batchelor T,Carson K,O'Neill A,et al.Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy:a report of NABTT 96-07[J].J Clin Oncol,2003,21 (6):1044-1049.
  • 5Bataille B,Delwail V,Menet E,et al.Primary intracerebeal malignant lymphoma:report of 248 cases[J].J Neuroesurg,2000,92 (2):261-266.
  • 6Basso U,Brandes A A.Diagnostic advances and new trends for the treatment of primary central nervous system lymphoma[J].Eur J Cancer,2002,38(10):1298-1312.
  • 7Shenkier T N,Blay J Y,O'Neill B P,et al.Primary CNS lymphoma of T-cell origin:a descriptive analysis from the international primary CNS lymphoma collaborative group[J].J Clin Oncol,2005,23 (10):2233-2239.
  • 8Sacktor N.The epidemiology of human immunodeficiency virusassociated neurological disease in the era of highly active antiretroviral therapy[J].J Neurovirol,2002,8 (Suppl 2):115-121.
  • 9Ferreri A J,Reni M,Villa E.Therapeutic management of primary central nervous system lymphoma:lessons from prospective trials[J].Ann Oncol,2000,11 (8):927-937.
  • 10Schultz C,Scott C,Sherman W,et al.Preirradiation chemotherapy with cyclophosphamide,doxorubicin,vincristine,and dexamethasone for primary CNS lymphomas:initial report of Radiation Therapy Oncology Group Protocol 88-06[J].J Clin Oncol,1996,14(2):556-564.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部